India-EU FTA nears finish line: 96% tariff cuts, EUR 4 billion savings, 1 lakh car quota for EU
12 Sept, 04:23 IST · Plays out over months · 4 sources
India and Europe are close to a big trade deal scrapping most import taxes — exporters of clothes, medicines and chemicals earn more, while Indian carmakers face cheaper European rivals.
Key facts
What the reporting establishes, before any reading of it.
- India-EU FTA nears finish: 96% tariff lines cut, EUR 4 billion duty savings
- EU gets tariff quota for 1 lakh cars; deal gets green light for next big move toward signing
- Textiles, pharma, chemicals named as export winners; auto OEMs face import competition
How the news spreads
Step by step — from the first companies it hits to whole sectors.
Who it hits first
- Textile, pharma and chemical exporters gain zero-duty EU access worth EUR 4 billion in saved duties
- Domestic premium auto faces cheaper EU imports under the 1 lakh car quota
- Capital-goods buyers gain cheaper EU machinery, aiding the capex cycle
Who may gain
- Textile exporters (KPR Mill, Welspun rallied 4-7% on earlier EU news in Jan 2026)
- Pharma formulation and API exporters
- Chemical and auto-component exporters
Along the supply chain
Downstream
EU distributors and retailers source more from India; Indian car dealers add EU import inventory.
Upstream
Yarn, API-intermediate and chemical-feedstock suppliers see stronger export-maker demand.
Where demand moves
Business
EU importers shift orders toward Indian suppliers as duties fall to zero, filling textile, pharma and chemical order books over 2-4 quarters; EU carmakers ship 1 lakh cars into India, contesting premium share.
Capital
Money rotates into export-oriented mid-caps on multi-year earnings upgrades; auto OEMs derate mildly on competitive fears until quota details clarify.
How it spreads across sectors
Chemicals
positive — export margins expand
Healthcare
positive — formulations and API access widens
Textiles
positive — duty-free access is the single biggest margin lever in years
When it plays out
Immediate
Export mid-caps pop 2-6% on headlines; auto OEMs dip 1-2%
Medium term
Order-book and capex cycle plays out over 1-3 years as duties phase to zero
Short term
Quota fine print and phase-in schedules decide real winners; weak names fade (history: ORCHPHARMA +28% 1w then flat 1m)